Other Viruses Citation List: April 27 - May 10, 2012

Hepatitis B virus

1. A Novel Inhibitor of Human La Protein with anti-HBV Activity Discovered by Structure-based Virtual Screening and in Vitro Evaluation. Tang, J., Z.M. Huang, Y.Y. Chen, Z.H. Zhang, G.L. Liu, and J. Zhang, PloS One, 2012. 7(4): p. e36363; PMID[22558448].
[PubMed]. OV_0427-051012.

Hepatitis C Virus

2. Novel 1,2,4-Triazole and Imidazole Derivatives of L-Ascorbic and Imino-ascorbic acid: Synthesis, anti-HCV and Antitumor Activity Evaluations. Wittine, K., M. Stipkovic Babic, D. Makuc, J. Plavec, S. Kraljevic Pavelic, M. Sedic, K. Pavelic, P. Leyssen, J. Neyts, J. Balzarini, and M. Mintas, Bioorganic & Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22555152].
[PubMed]. OV_0427-051012.

3. Novel Small-molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture. Coburn, G.A., D.N. Fisch, S.M. Moorji, J.M. de Muys, J.D. Murga, D. Paul, K.P. Provoncha, Y. Rotshteyn, A.Q. Han, D. Qian, P.J. Maddon, and W.C. Olson, PloS One, 2012. 7(4): p. e35351; PMID[22545104].
[PubMed]. OV_0427-051012.

4. Tegobuvir (GS-9190) Potency against HCV Chimeric Replicons Derived from Consensus NS5B Sequences from Genotypes 2b, 3a, 4a, 5a, and 6a. Wong, K.A., S. Xu, R. Martin, M.D. Miller, and H. Mo, Virology, 2012. [Epub ahead of print]; PMID[22543048].
[PubMed]. OV_0427-051012.

5. Finger-loop Inhibitors of the HCV NS5b Polymerase. Part 1: Discovery and Optimization of Novel 1,6- and 2,6-Macrocyclic Indole Series. McGowan, D., S. Vendeville, T.I. Lin, A. Tahri, L. Hu, M.D. Cummings, K. Amssoms, J.M. Berke, M. Canard, E. Cleiren, P. Dehertogh, S. Last, E. Fransen, E. Van Der Helm, I. Van den Steen, L. Vijgen, M.C. Rouan, G. Fanning, O. Nyanguile, K. Van Emelen, K. Simmen, and P. Raboisson, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22542193].
[PubMed]. OV_0427-051012.

6. Identification of Aryl dihydrouracil Derivatives as Palm Initiation Site Inhibitors of HCV NS5B Polymerase. Liu, Y., B.H. Lim, W.W. Jiang, C.A. Flentge, D.K. Hutchinson, D.L. Madigan, J.T. Randolph, R. Wagner, C.J. Maring, W.M. Kati, and A. Molla, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22542020].
[PubMed]. OV_0427-051012.

FIV

7. Efficacy and Adverse Effects of the Antiviral Compound Plerixafor in Feline Immunodeficiency Virus-infected Cats.. Hartmann, K., C. Stengel, D. Klein, H. Egberink, and J. Balzarini, Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine, 2012. 26(3): p. 483-90; PMID[22551322].
[PubMed]. OV_0427-051012.

HSV-1

8. In Vitro Study of the Effect of a Probiotic Bacterium Lactobacillus rhamnosus against Herpes Simplex Virus Type 1. Khani, S., M. Motamedifar, H. Golmoghaddam, H.M. Hosseini, and Z. Hashemizadeh, The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases, 2012. 16(2): p. 129-35; PMID[22552453].
[PubMed]. OV_0427-051012.

9. HSV-1 miR-H6 Inhibits HSV-1 Replication and IL-6 Expression in Human Corneal Epithelial Cells In Vitro. Duan, F., J. Liao, Q. Huang, Y. Nie, and K. Wu, Clinical & Developmental immunology, 2012. [Epub ahead of print]: p. 192791; PMID[22550533].
[PubMed]. OV_0427-051012.

Citations from the ISI Web of Knowledge Listings for O.V.

10. Synthesis of Novel Thienonorbornylpurine Derivatives. Hrebabecky, H., M. Dejmek, M. Sala, H. Mertlikova-Kaiserova, M. Dracinsky, P. Leyssen, J. Neyts, and R. Nencka, Tetrahedron, 2012. 68(15): p. 3195-3204; PMID[WOS:000302593200008].
[WOS]. OV_0427-051012.

11. Nucleoside, Nucleotide, and Non-nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. Sofia, M.J., W.S. Chang, P.A. Furman, R.T. Mosley, and B.S. Ross, Journal of Medicinal Chemistry, 2012. 55(6): p. 2481-2531; PMID[WOS:000301767000001].
[WOS]. OV_0427-051012.

12. Azithromycin Inhibits Hepatitis C Virus Replication in Hepatocytes. Ye, L., M. Guo, J.L. Li, X. Wang, Y.Z. Wang, Y. Zhou, and W.Z. Ho, Journal of Neuroimmune Pharmacology, 2012. 7: p. S80-S80; PMID[WOS:000302288800198].
[WOS]. OV_0427-051012.

13. Antioxidant and Antiviral Activities of Lipophilic Epigallocatechin Gallate (EGCG) Derivatives. Zhong, Y., C.M. Ma, and F. Shahidi, Journal of Functional Foods, 2012. 4(1): p. 87-93; PMID[WOS:000301884800009].
[WOS]. OV_0427-051012.